Unique ID issued by UMIN | UMIN000044853 |
---|---|
Receipt number | R000051231 |
Scientific Title | Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study |
Date of disclosure of the study information | 2021/07/13 |
Last modified on | 2021/07/13 18:30:25 |
Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study
Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study
Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study
Effects of Kampo medicine Hochuekkito on fatigue and health-related quality of life in hemodialysis patients with chronic kidney disease: a pilot study
Japan |
Chronic kidney disease stage G5D
Nephrology |
Others
NO
To evaluate the efficacy of traditional Kampo medicine hochuekkito on fatigue or health-related quality of life in CKD patients with hemodialysis.
Efficacy
Chalder fatigue scale
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Hochuekkito extract granules 7.5g/day
for 2 months
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients who have obtained their consent
2. Age >= 20 y.o.
3. Chronic kidney disease patients with hemodialysis for more than 3 months
4. Chalder Fatigue Scale (CFS) >= 19
5. Patients who can answer the questionnaire
1. Pregnant or possibly pregnant
2. A history of allergies to hochuekkito
3. Severe hypertension (>= 180/110 mmHg)
4. Onset of cardiovascular disease within 1 month
5. Severe complications including blood disorders, active malignancies, infectious diseases, thyroid disorders, and depression
6. Using steroids, immunosuppressants (e.g. cyclosporine), and glycyrrhizin
7. Using other Kampo medicines
8. Participating in another clinical trial
9. Participants who are judged to be inappropriate
60
1st name | Kazushi |
Middle name | |
Last name | Uneda |
Aizu Medical Center, Fukushima Medical University School of Medicine
Department of Kampo Medicine
969-3492
21-2 Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, Fukushima 969-3492, Japan
0242-75-2100
uneda@fmu.ac.jp
1st name | Kazushi |
Middle name | |
Last name | Uneda |
Aizu Medical Center, Fukushima Medical University School of Medicine
Department of Kampo Medicine
969-3492
21-2 Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, Fukushima 969-3492, Japan
0242-75-2100
uneda@fmu.ac.jp
Fukushima Medical University School of Medicine
Fukushima Medical University School of Medicine
Other
Fukushima Medical University Certified Review Board
1 Hikariga-oka, Fukushima City, Fukushima, 960-1295 Japan
024-547-1825
fmucrb@fmu.ac.jp
YES
RK2020-008
Fukushima Medical University Certified Review Board
2021 | Year | 07 | Month | 13 | Day |
Unpublished
Open public recruiting
2021 | Year | 03 | Month | 23 | Day |
2021 | Year | 03 | Month | 23 | Day |
2021 | Year | 07 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
2021 | Year | 07 | Month | 13 | Day |
2021 | Year | 07 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051231
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |